WallStreetZenWallStreetZen

NASDAQ: SNY
SANOFI Earnings & Revenue

OverviewForecastEarnings
DividendOwnership

SNY past earnings growth

How has SNY's earnings growth performed historically?
Company
-52.79%
Industry
97.28%
Market
92.76%
SNY's earnings have grown slower... subscribe to Premium to read more.
Earnings Growth vs Industry Performance
SNY's earnings have grown slower... subscribe to Premium to read more.
Earnings Growth vs Market Performance
SNY's earnings growth is slowing... subscribe to Premium to read more.
Accelerating Earnings Growth Performance

SNY past revenue growth

How has SNY's revenue growth performed historically?
Company
-2.31%
Industry
24.91%
Market
51.15%
SNY's revenue has grown slower... subscribe to Premium to read more.
Revenue Growth vs Industry Performance
SNY's revenue has grown slower... subscribe to Premium to read more.
Revenue Growth vs Market Performance
SNY's revenue growth is slowing... subscribe to Premium to read more.
Accelerating Revenue Growth Performance

SNY earnings and revenue history

Current Revenue
$44.5B
Current Earnings
$7.1B
Current Profit Margin
15.9%
SNY's has not demonstrated consistent... subscribe to Premium to read more.
Long-term Earnings Growth Trend Performance

SNY Return on Equity

Current Company
9.4%
Current Industry
34.4%
Current Market
177.3%
SNY's Return on Equity (9.5%)... subscribe to Premium to read more.
High Return on Equity Performance

SNY Return on Assets

Current Company
5.3%
Current Industry
10.2%
SNY is generating lower Return... subscribe to Premium to read more.
Above Average Return on Assets Performance

SNY Return on Capital Employed

Current Company
8.24%
Current Industry
15%
SNY has gotten more efficient... subscribe to Premium to read more.
Increasing Return on Capital Employed Performance

SNY vs General Drug Manufacturer Stocks

TickerRevenueEBITDAEarningsY/Y RevenueY/Y Earnings
SNY$44.52B$13.07B$7.07B+4.04%+7.95%
AMGN$26.32B$11.12B$5.72B+2.79%-0.84%
GSK$45.60B$11.44B$6.39B+5.77%+25.68%
BMY$46.96B$17.84B$6.25B+18.66%-0.49%
GILD$27.47B$8.97B$4.52B-1.15%-17.76%
View Top General Drug Manufacturer Stocks

SANOFI Earnings & Revenue FAQ

What were SNY's earnings last quarter?

SANOFI (NASDAQ: SNY) reported Q4 2021 earnings per share (EPS) of N/A, up N/A year over year. Total SANOFI earnings for the quarter were N/A. In the same quarter last year, SANOFI's earnings per share (EPS) was N/A.

What was SNY's earnings growth in the past year?

As of Q2 2022, SANOFI's earnings has grown -52.79% year over year. This is 150.08 percentage points lower than the US Drug Manufacturers - General industry earnings growth rate of 97.28%. SANOFI's earnings in the past year totalled $7.07 billion.

What was SNY's revenue last quarter?

SANOFI (NASDAQ: SNY) reported Q4 2021 revenue of N/A up N/A year over year. In the same quarter last year, SANOFI's revenue was N/A.

What was SNY's revenue growth in the past year?

As of Q2 2022, SANOFI's revenue has grown -2.31% year over year. This is 27.22 percentage points lower than the US Drug Manufacturers - General industry revenue growth rate of 24.91%. SANOFI's revenue in the past year totalled $44.52 billion.
©2022 WallStreetZen
Company
AboutBlogPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContact
Stocks
Stock ScreenerStock ForecastHighest Earnings StocksBest Dividend Paying StocksStatisticsTrending StocksStock Market SectorsStock Market Industries
Analysts
Top Performing Analysts
Social
TwitterYouTube
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.